Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
120.23
-5.32 (-4.24%)
At close: Aug 27, 2026, 4:00 PM EDT
122.00
+1.77 (1.47%)
After-hours: Aug 27, 2026, 6:14 PM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $10 billion as of August 27, 2026. Its market cap has increased by 218.73% in one year.
Market Cap
10.00B
Enterprise Value
8.57B
1-Year Change
218.73%
Ranking
Category
Stock Price
$120.23
ChartMarket Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $10.00B, an increase of 1,098.01%. That is a compound annual growth rate of 51.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 10.00B | 60.60% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Techne | 11.36B |
| Summit Therapeutics | 11.28B |
| Cytokinetics | 10.98B |
| ABIVAX Société Anonyme | 10.94B |
| Axsome Therapeutics | 10.76B |
| Krystal Biotech | 10.69B |
| Ionis Pharmaceuticals | 10.51B |
| Praxis Precision Medicines | 10.51B |